171 related articles for article (PubMed ID: 10613023)
1. Pearls and pitfalls of interferon beta treatment for multiple sclerosis.
Corona T; León C; Ruiz JL
Neurologia; 1999 Nov; 14(9):467-8. PubMed ID: 10613023
[No Abstract] [Full Text] [Related]
2. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
[TBL] [Abstract][Full Text] [Related]
3. Interferon beta for treatment of multiple sclerosis.
Wilson BA
Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
[No Abstract] [Full Text] [Related]
4. [High doses of interferon in the treatment of multiple sclerosis].
Muñoz D
Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
[No Abstract] [Full Text] [Related]
5. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
Pender MP
J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
[No Abstract] [Full Text] [Related]
6. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
Hodgkinson SJ
J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
[No Abstract] [Full Text] [Related]
7. The treatment of multiple sclerosis with beta-interferon.
Poser CM
Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413
[No Abstract] [Full Text] [Related]
8. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
Macdonell R
J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
[No Abstract] [Full Text] [Related]
9. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
Oger J; Gibbs E
Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528
[No Abstract] [Full Text] [Related]
10. [New therapeutic methods in the treatment of multiple sclerosis].
Nervenarzt; 1996 Nov; 67(11 Suppl Neue Ther):1-12. PubMed ID: 9402424
[No Abstract] [Full Text] [Related]
11. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
[No Abstract] [Full Text] [Related]
12. Interferons in multiple sclerosis.
Kappos L
Neurol Clin; 2005 Feb; 23(1):189-214, vii-viii. PubMed ID: 15661094
[No Abstract] [Full Text] [Related]
13. Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions.
Carrieri PB; Petracca M; Montella S; Delfino M; Sepe C; Gattoni A
Ann Rheum Dis; 2008 Aug; 67(8):1192-3. PubMed ID: 18621969
[No Abstract] [Full Text] [Related]
14. The use of interferon beta in relapsing-remitting multiple sclerosis.
Etheridge LJ; Beverley DW; Ferrie C; McManus E
Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
[TBL] [Abstract][Full Text] [Related]
15. [Interferon beta-1a].
Taéron C
Rev Infirm; 2004 May; (101):39-40. PubMed ID: 15984751
[No Abstract] [Full Text] [Related]
16. 10 years of interferon beta-1b (Beta feron therapy.
Kappos L; Hartung HP
J Neurol; 2005 Sep; 252 Suppl 3():iii1-iii2. PubMed ID: 16170493
[No Abstract] [Full Text] [Related]
17. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
Duchini A
Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
[No Abstract] [Full Text] [Related]
18. [Betaferon and therapy of multiple sclerosis--present and future].
Hohlfeld R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():1. PubMed ID: 11603109
[No Abstract] [Full Text] [Related]
19. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
Horowski R; Stürzebecher CS; Kapp JF
Funct Neurol; 2001; 16(2):117-28. PubMed ID: 11495417
[No Abstract] [Full Text] [Related]
20. [Combined treatment of multiple sclerosis. A case report].
Fonseca A; Noda M; González I; Gámez O; Montoya A; Daudinot B
Rev Neurol; 2001 May 16-31; 32(10):996-8. PubMed ID: 12809119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
